Odysight.ai Insider Moves Signal Confidence, Await FDA Approval for AI Diagnostic Tool
Odysight.ai insider trades reveal strong executive confidence, promising AI‑driven diagnostics and upcoming FDA clearance, yet investors face volatility and regulatory risk.
4 minutes to read